Showing posts with label for Joan. Show all posts
Showing posts with label for Joan. Show all posts

Monday, November 2, 2020

November is Lung Cancer Awareness Month

Lung cancer matters, too.  Nobody deserves it.  And, you do not have to smoke to get it. 

This year, nearly 230,000 Americans will be diagnosed with Lung Cancer.  It is the Leading Cause of cancer death in the United States.  It claims more lives annually than either Colorectal, Pancreatic, Breast, or Prostate cancers.  And nearly 20% of those diagnosed with Lung Cancer have never smoked.

Yet, it receives a small fraction of the ​attention and research funding.  

Help fight to change this!

Tuesday, January 7, 2020

The GO2 Foundation for Lung Cancer Brings Their Lung Cancer Living Room to Atlanta!


Every month, The GO2 Foundation for Lung Cancer hosts their “Lung Cancer Living Room” from their headquarters in San Carlos, CA.  It is an education and support group for patients and their families. It is a forum for presentations by lung cancer specialists, physicians, and researchers.  The session is an unrestricted forum covering all topics: early detection, treatment options, molecular and genetic testing, clinical trials, drug discoveries, personalized medicine, nutrition, surgical equipment and procedures, up-to-date news about advancements, and more.  They share personal stories, get/give advice and support, and share critical information from doctors and researchers. 

This month, they are bringing their show on the road to Atlanta, Georgia!

Topic
Why Biomarker Testing is Important

Moderator

Jennifer King, PhD - Senior Director, Science and Research - GO2 Foundation for Lung Cancer

Speakers from the Winship Cancer Institute of Emory University

Dr. Suresh Ramalingam - Medical Oncologist
Dr. Drew Moghanaki - Radiation Oncologist
Dr Onkar Khullar - Cardiothoracic Surgeon
Dr. Charles Hill - Pathologist

Date / Time

Wednesday, January 22nd, 2020 from 5:30 to 7:30 pm Eastern Standard Time
(In person attendees are invited for dinner at 5:00pm.)

Where

Emory Conference Center Hotel / Garden Level - Azalea Room
1615 Clifton Road
Atlanta, Georgia
(Or, in your living room via YouTube or Facebook!)

How to Participate
All interested patients, caregivers, advocates, and health care professionals are encouraged to join the conversation. There are three ways to participate:
  1. In Person – If you live close to Atlanta, join for dinner and conversation (see above).
  2. Facebook Livefacebook.com/GO2Foundation – tune in at 5:30 pm ET and ask questions online.
  3. YouTube Liveyoutube.com/GO2FoundationforLungCancer – tune in at 5:30 pm ET.
Click HERE to download the flyer.  Print! Email! Share!

More info:  Contact the Patient Services Team at (650) 598-2857 or livingroom@go2foundation.org.

Wednesday, September 4, 2019

Lung Cancer matters, too.

Nobody deserves it.  And, you do not have to smoke to get it. Lung cancer kills more people than breast, prostate, colon, liver, kidney, and melanoma cancers combined. ​Yet, it receives a small fraction of the ​attention and research funding.  Help fight to change this!

How? By supporting my dear friends at the GO2 Foundation for Lung Cancer.
Check out the latest lung cancer facts...
Click on the image for the complete fact sheet.

And read about lung cancer's unique impact on women here...
Click on the image for the complete fact sheet.

This information may save a life.

Wednesday, August 14, 2019

A five minute video that could save your life or the life of someone you love....

Please take a moment and watch this excellent, informative video about low dose CT lung cancer screening.  Early detection saves lives. 

More great work from my friends at the GO2 Foundation for Lung Cancer.


Lung cancer matters, too. Nobody deserves it.  And, you do not have to smoke to get it. Lung cancer kills more people than breast, prostate, colon, liver, kidney, and melanoma cancers combined. ​Yet, it receives a small fraction of the ​attention and research funding.  Help fight to change this! Please share with your network.

Lung Cancer Facts       ::       Why I Do This

Wednesday, August 1, 2018

Today is World Lung Cancer Day.

August 1 is celebrated as World Lung Cancer Day
Lung cancer matters, too. Nobody deserves it. And, you do not have to smoke to get it.

Lung cancer kills more people than breast, prostate, colon, liver, kidney, and melanoma cancers combined.

Yet, it receives a small fraction of the attention and research funding. We are fighting to change this.

Please consider a donation today:
https://www.supportalcf.org/InLovingMemory/joangaeta

Learn more:
GaetaFund.org

Tuesday, November 14, 2017

ALCF and ALCMI: Who They Are and What They Do

We are about halfway through Lung Cancer Awareness Month and I would like to offer some information about a fantastic organization. If you are reading this, you likely know about this group. But, even if you do, I encourage you to sit back with your favorite beverage and take a few minutes to watch the video at the end of this post.

When supporting any cause or charity with a financial gift, prudent questions are “Where does the money go?”“How effective is the organization?”“Is it worthy of my support?”, "What are they doing?", "What have they done?" I ask these questions myself before choosing to financially support any charitable cause.

This video, narrated by their Senior Director of Patient Services and Programs, Danielle Hicks, does an excellent job of answering these questions for The Bonnie J.  Addario Lung Cancer Foundation (ALCF).

I met the Addarios shortly after my mother died in 2007.  I was immediately struck by their sincerity, warmth - and tenacity.  But, I was also impressed by their team and how they were attacking the lung cancer problem with intelligence and professionalism.  In 2010, The Joan Gaeta Lung Cancer Fund proudly became an affiliate of ALCF.  And, since 2012, those of you in Georgia have been able to order Lung Cancer Awareness License Plates - a first in the United States.  85% of the annual tag fee goes to ALCF’s research institute.

You can also donate directly to ALCF via this link.  Please to watch the video and consider a donation during this important month.

Thank you.


Monday, August 14, 2017

A new way to donate....

The Joan Gaeta Lung Cancer Fund
​​Lung cancer matters, too. Nobody deserves it. And, you do not have to smoke to get it. Lung cancer kills more people than breast, prostate, colon, liver, kidney, and melanoma cancers combined. Yet, it receives a mere fraction of the ​attention and research funding. We are fighting to change this. 

Please help us in our continuing effort..... Donate today.

Friday, March 10, 2017

Sunday, July 31, 2016

World Lung Cancer Day (August 1st ) Commemorates, Celebrates, and Supports Those Impacted by Lung Cancer

GLENVIEW, Ill. (July 29, 2016) – On World Lung Cancer Day on August 1, the American College of Chest Physicians (CHEST), alongside members of the Forum of International Respiratory Societies (FIRS) commemorates, celebrates and supports those impacted by lung cancer. FIRS joins the grassroots efforts of the lung cancer community to raise awareness about lung cancer and its global impact, creating an educational movement of understanding lung cancer risks as well as early treatment around the world.

Lung cancer is the most common cancer worldwide, accounting for 1.8 million new cases in 2012, and is responsible for nearly one in five cancer deaths according to the World Health Organization. Lung cancer claims more lives yearly than breast, colon and prostate cancers combined. According to the American Cancer Society, an estimated 224,390 new cases of lung cancer are expected to be diagnosed in 2016, accounting for about 14% of all cancer diagnoses in the United States alone.

World Lung Cancer Day 2016: Honor, Unite, Inspire highlights the many risk factors to be aware of in order to detect lung cancer at the earliest stage possible. While most understand that smoking is the single greatest risk factor for lung cancer, other lesser known risk factors include environment and genetics. Environmental exposure to radon, asbestos, arsenic, beryllium and uranium have all been linked to lung cancer. The risk of lung cancer also increases with a history of cancer in another part of the body, age, family history, radiation to the chest area and lung diseases like COPD.

The initiative also aims to shed light on key symptoms and screening options. Symptoms include change in mucus, chest or back pain, coughing up blood and difficulty swallowing. Tests that may be used to diagnose lung cancer include chest X-rays, CT and PET scans, bronchoscopy and needle biopsies. If you are a current or former smoker and over age 55, you may be a candidate for a low- dose CT scan screening that can offer early detection of lung cancer, potentially at its earliest stages.

“Treatment options for lung cancer have significantly advanced over the past few years and survival rates are increasing. We’re hopeful the World Lung Cancer Day efforts will help to continue to raise awareness of risks and increase early detection for the best possible outcomes,” said Dr. Gerard Silvestri, President-Elect of the American College of Chest Physicians.

More than 70,000 global FIRS members have united in support of World Lung Cancer Day, including member organizations: CHEST, Asociación Latinoamericana del Thorax (ALAT), the American Thoracic Society, the Asian Pacific Society of Respirology, the European Respiratory Society, the International Union Against Tuberculosis and Lung Disease and the Pan African Thoracic Society.

Patients, families and caregivers can download free educational resources and learn more about lung cancer, risk factors, screenings and treatment options by visiting http://www.chestnet.org/WLCD.

About CHEST
CHEST is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research and team-based care. Its mission is to champion the prevention, diagnosis and treatment of chest diseases through education, communication and research. CHEST serves as an essential connection to clinical knowledge and resources for its 19,000 members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For more information, visit chestnet.org.

About the Forum of International Respiratory Societies
FIRS is an organization consisting of the world’s leading international respiratory societies working together to improve lung health globally: American Thoracic Society, CHEST, Asociación Latinoamericana De Tórax, Asian Pacific Society of Respirology, European Respiratory Society, International Union Against Tuberculosis and Lung Diseases and the Pan African Thoracic Society. The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally.

Contact: Kristi Bruno, kbruno@chestnet.org

Friday, October 30, 2015

Why Quitting Smoking Won't Eliminate Lung Cancer Deaths

by Lynne Eldridge MD. Originally posted on 30 October 2015 at About.com.

Many of us have been upset recently as well-meaning organizations have made smoking cessation the focus of lung cancer awareness month.  Certainly, encouraging the public to never begin, and to quit if they smoke, is admirable. And for people with lung cancer, quitting may improve survival.  Yet lung cancer awareness month should have a different focus.

Spreading information on smoking cessation does little overall for those living with lung cancer todayFive months after receiving a diagnosis of lung cancer, only 14% of people with the disease are smokers.  To focus on smoking is analogous to making breast cancer awareness month all about informing women that they should have their first child before the age of 30 (to decrease the risk of breast cancer.) Awareness month should be about supporting people with the disease, not about discussing the causes.

Awareness month should also be about funding to research better treatments. Those who smoked in the past won't benefit from a lecture about what they may have done differently 20 years ago.  Instead, they need treatment today. And for never smokers with the disease--not uncommon considering lung cancer in never smokers is the 6th leading cause of cancer deaths in the U.S.--this focus makes a month designed to celebrate their lives irrelevant. 

Some people may remain skeptical, but read on for further reasons why lung cancer awareness month should not have smoking cessation as the central focus.

The majority of people with lung cancer are non-smokers.

This heading is not a typo.  The majority—roughly 60% of people—diagnosed  with lung cancer are non-smokers.  This includes people who smoked at some time in the past, as well as never smokers.  In the United States 20% of women with lung cancer are never smokers, with that number rising to 50% of women with lung cancer worldwide.

Numbers such as 20% may seem small, until you take a look at the statistics.

Lung cancer is the leading cause of cancer deaths in both men and women in the United States.  Lung cancer kills twice as many women as breast cancer, and 3 times as many men as prostate cancer.  

And while around 30 to 40% of people smoke at the time of diagnosis, only 14% of people with lung cancer are smoking 5 months after diagnosis.

In other words, the vast majority of people with lung cancer today will not benefit from hearing about the hazards of smoking.  Not only is this focus not helpful, but it serves to propagate the stigma of lung cancer as a smoker's disease.  Unfortunately this vast majority, including most never smokers, have already been subjected to the blame game.  Have breast cancer?  Nice.  People act loving and ask how they can help you.  Have lung cancer?  Raised eyebrows accompanied by some variation of the question,"How long did you smoke?"  
There are many reasons that living with lung cancer can be harder than living with breast cancer.  Let's not add cancer awareness month to the list.

There are Other Causes of Lung Cancer

There are many causes of lung cancer. Even if tobacco had never been introduced on the planet, we would still have lung cancer.  Yes, smoking is the leading cause of lung cancer, but causes other than smoking are very important.  Though the number seems small—20%  of women who develop lung cancer being never smokers—this translates to a fifth of the 71,660 lung cancer deaths in women expected for 2015.

Radon exposure in the home is the second leading cause of lung cancer, and the number one cause of lung cancer in non-smokers.

Roughly 21,000 people die from radon-induced lung cancer each year, and this cause is entirely preventable.  Picking up a radon test kit from the hardware store for around 10 bucks, and having radon mitigation done if the test is abnormal, is all that's needed.

Putting these numbers in perspective may help.  Around 39,000 women are expected to die from breast cancer in 2015.  If we had a $10 test to check for a risk factor, and a procedure costing less than a grand that could completely prevent half of breast cancer deaths, do you think we would have heard?  Why doesn't the public know about this?  It goes back to the focus of this article; we are placing the emphasis of lung cancer awareness on smoking, and in doing so, are leaving the public with a false sense of assurance that all's well if you don't smoke.

There are other causes worth mentioning, from air pollution, to indoor air pollution, to secondhand smoke, to occupational hazards.  Don't assume you are safe if you never smoked.

Learn about the other causes of lung cancer in non-smokers and what you can do to reduce your risk.

People Who Have Quit Smoking Are Still at Risk

Quitting smoking certainly reduces the risk of lung cancer, but for most, some risk always remains.  The numbers in the last slide attest to this.  There are more former smokers who develop lung cancer each year than current smokers.

If you smoked in the past, don't fret yet.  After 10 years of quitting, the risk of lung cancer decreases by 30 to 50%. There are also some ways of reducing your risk of dying from lung cancer.

One method is low dose CT lung cancer screening.  While screening doesn't lower the chance that you will get lung cancer, it does increase the chance that if you develop lung cancer, it will be found in the earlier, more curable stages of the disease.  It's thought that screening people at risk could reduce the mortality rate from lung cancer by 20% in the United States.  Screening is currently recommended for people between the ages of 55 and 80, who have a 30 pack-year history of smoking, and continue to smoke or quit within the past 15 years.  In some cases screening may be recommended for other people based on personal risk factors for lung cancer.

In addition, studies looking at exercise and lung cancer as well as diet and lung cancer suggest there are some things that both people without and people with lung cancer can do to lessen risks. 

The Stigma Interferes With Early Diagnosis

My favorite part of lung cancer events I attend, is when lung cancer survivors share their story.  A special time, but oh so painful.  Time and time again people share what eventually led to their diagnosis -- often a series of visits, with several doctors, over a period of months, during which time they have been diagnosed with everything from asthma to Lyme disease.

Lung cancer flies below the radar screen for many health care professionals, especially lung cancer in never smokers and lung cancer in young adults.

For this reason, many are diagnosed when lung cancer has already spread, and the chance of a cure with surgery has passed.  In fact, young adults and never smokers are more likely to be diagnosed at an advanced stage of the disease.

Until we have a widespread screening tool for lung cancer, it's important for health professionals and patients alike, to realize that all you need to get lung cancer is lungs.  The symptoms of lung cancer can be different in non-smokers than smokers, and those of lung cancer in women are often different than symptoms in men.  Be your own advocate.  If you have any symptoms that aren't adequately explained, ask for a better explanation or a second opinion.  If we are to find lung cancer early, we need to dispel the myth that lung cancer is a smoker's disease.  That's part of what lung cancer awareness month is all about.

The Stigma Interferes With Research for New Treatments

Private funding for breast cancer surpasses that of lung cancer by a great distance, as evidenced by Susan G. Komen being a household word and pink ribbons having a widely recognized significance.  How many people can name the largest non-profits for lung cancer, and how many people even know the color of the lung cancer ribbon?

Public funding also lags far behind for lung cancer, and this is important because funding means dollars which in turn means research.

In 2012, federal research spending added up to $26,398 per life lost to breast cancer, vs only $1,442 per life lost from lung cancer.  I have often wondered what the survival rate for lung cancer would be if the same amount of money and research had been invested as has been with breast cancer.

Why is the funding so low, and why are researchers less likely to devote themselves to lung cancer?  The stigma.  There is an unseen, unheard statement that says, "These people smoked so they deserve to have cancer."  Nobody deserves to have lung cancer, whether a never smoker or a lifelong smoker. Making smoking cessation the focus of lung cancer awareness only increases this stigma and gap. 

The Stigma Interferes With Research About Causes

I made a comparison earlier about deaths from breast cancer, vs that from radon-induced lung cancer. That can be taken a step further.  I read studies galore looking at possible causes of breast cancer, as well as dietary and other measures which may reduce the risk. It's rare when I find similar studies looking at lung cancer.  

What is causing lung cancer in non-smokers?  Why is lung cancer increasing in young, never smoking women?

We need to change the face of lung cancer, so that we can begin to look at possible answers to these questions.

Lung Cancer is Increasing in Young, Never-Smoking Women

Most of us have read the headlines in recent years.  Lung cancer in men is now decreasing in the United States, while that in women has leveled off.  Yet there is one group for whom lung cancer is steadily increasing.  Young, never-smoking women.

These women have to put up with constant questions about their smoking status, or another variant, "Did your parents smoke when you were growing up?" 
Why can't we treat these women as we treat women with breast cancer in October?

Lung cancer isn't a "smoker's disease."  Someone with lung cancer could be your mother or your daughter or your sister or your aunt. These young women deserve to know that they aren't being dismissed for having a smoker's disease, while at the same time coping with the stigma.

Focus of Lung Cancer Awareness Month

Okay.  So smoking cessation shouldn't be the focus of lung cancer awareness month.  What should be at the center of awareness?

Number one should be support.  Every single person with lung cancer -- regardless of smoking history -- deserves our love, compassion, and the best care possible. Think of how women are treated during breast cancer awareness month, how they are celebrated, how they are reminded that research is being done to make a difference.

If you just don't know what to say, check out these tips on things not to say to someone with lung cancer.  How would you treat your friend or loved one with lung cancer differently, if she had breast cancer instead?

Number two should be about awareness.  Not smoking cessation as this is done everywhere year round.  Instead awareness that lung cancer occurs in non-smokers and having knowledge of the early symptoms could make a difference. Those who are former smokers should have the opportunity to learn about screening options.

And just as breast cancer awareness month raises funds for research, lung cancer awareness month should also be a time to educate and encourage those with lung cancer about new advances, while providing funding for further advances.

A Word About Smoking and Lung Cancer

For smokers with lung cancer, quitting is critical. To speak of separating lung cancer awareness month from smoking is not to dismiss smoking as a cause of lung cancer.  It is.  

For the minority of people living with lung cancer who smoke, quitting is incredibly important, and likely the most important thing anyone can do to improve survival.  Check out these 10 reasons to quit smoking after a diagnosis of cancer. Quitting smoking after a diagnosis of lung cancer improves the response to cancer treatments, improves quality of life, and improves survival.

For those without lung cancer, quitting not only reduces lung cancer risk, but improves survival in other ways. In addition to lung cancer, there are many cancers that are associated with smoking, and many other medical conditions associated with smoking.

The Quit Smoking Toolbox is a free resource to help you gather the tools you need to be successful in giving up the habit.

But remember that these tips on smoking and cancer were placed at the end for a reason.  They apply to only a minority of people living with lung cancer today.


Sources:
Amato, D. et al. Tobacco Cessation May Improve Lung Cancer Patient SurvivalJournal of Thoracic Oncology. 2015. 10(7):1014-9.
American Cancer Society. Cancer Facts & Figures 2015. Accessed 06/08/15. http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf
American Society of Clinical Oncology. Cancer.net Tobacco Use During Cancer Treatment. 04/2012. http://www.cancer.net/navigating-cancer-care/prevention-and-healthy-living/tobacco-use/tobacco-use-during-cancer-treatment
Amato, D. et al. Tobacco Cessation May Improve Lung Cancer Patient SurvivalJournal of Thoracic Oncology. 2015. 10(7):1014-9.
Howlader, N., Noone, A., Krapcho, M., Garshell, J., Miller, D., Altekruse, S., Kosary, C., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D., Chen, H., Feuer, E., and A. Cronin (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, based on November 2014 SEER data submission, posted to the SEER web site, April 2015. http://seer.cancer.gov/csr/1975_2012/
National Cancer Institute. Cancer Statistics. Accessed 06/08/15. http://www.cancer.gov/about-cancer/what-is-cancer/statistics
National Cancer Institute. Lung Cancer Prevention (PDQ). Updated 05/12/15. http://www.cancer.gov/types/lung/patient/lung-prevention-pdq#section/_12
National Cancer Institute. Smoking in Cancer Care—for Health Care Professionals. Accessed 08/01/15. http://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/smoking-cessation-hp-pdq#section/_1

Parsons, A. et al. Influence of smoking cessation after diagnosis of early-stage lung cancer on prognosis: systematic review of observational studies with meta-analysisBritish Medical Journal BMJ2010:340:b5569. Published online 21 January 2010.

Friday, August 15, 2014

Lung Cancer Matters, Too

Nobody deserves it. And, you do not have to smoke to get it.  It kills more people than breast, prostate, colon, liver, kidney, and melanoma cancers combined.  Yet, lung cancer receives a mere fraction of the attention and research funding.

Check out forJoan.org for the facts, resources, information, and the latest news.

Tuesday, June 24, 2014

Dare to be different!!!

Do you live in Georgia?  Get your Lung Cancer Awareness specialty license plate today!

Dare to be different and let your fellow motorists know that lung cancer matters, too!

Tuesday, June 17, 2014

New Study Aims to Rapidly Test Lung Cancer Drugs

Breyan Harris, a lifelong non-smoker who was recently diagnosed with lung cancer, posses at her home in Fair Oaks, Calif., Monday, June 16, 2014. Harris, 33, hopes to enroll in a new cancer drug test that starts Monday in hundred of hospitals around the country. Like a medical version of speed dating, doctors will sort through multiple potential drugs and match patients to the one most likely to succeed based on each person's unique tumor gene profile.(AP Photo/Rich Pedroncelli)
By MARILYNN MARCHIONEa
The Associated Press

A bold new way to test cancer drugs started Monday in hundreds of hospitals around the U.S. In a medical version of speed dating, doctors will sort through multiple experimental drugs and match patients to the one most likely to succeed based on each person's unique tumor gene profile.

It's a first-of-a-kind experiment that brings together five drug companies, the government, private foundations and advocacy groups. The idea came from the federal Food and Drug Administration, which has agreed to consider approving new medicines based on results from the study.

Its goal is to speed new treatments to market and give seriously ill patients more chances to find something that will help. Instead of being tested for individual genes and trying to qualify for separate clinical trials testing single drugs, patients can enroll in this umbrella study, get full gene testing and have access to many options at once.

The study, called Lung-MAP, is for advanced cases of a common, hard-to-treat form of lung cancer — squamous cell. Plans for similar studies for breast and colon cancer are in the works.

"For patients, it gives them their best chance for treatment of a deadly disease," because everyone gets some type of therapy, said Ellen Sigal, chairwoman and founder of Friends of Cancer Research, a Washington-based research and advocacy group that helped plan and launch the study. "There's something for everyone, and we'll get answers faster" on whether experimental drugs work, she said.

Cancer medicines increasingly target specific gene mutations that are carried by smaller groups of patients. But researchers sometimes have to screen hundreds of patients to find a few with the right mutation, making drug development inefficient, expensive and slow.

One of the leaders of the Lung-MAP study — Dr. Roy Herbst, chief of medical oncology at the Yale Cancer Center — said he once screened 100 patients to find five that might be eligible for a study, and ultimately was able to enroll two.

"It's just going to be impossible, in rare subgroups, for companies to find enough" people to try out a new medicine, said Dr. Richard Pazdur, cancer drugs chief at the FDA. He and others at the FDA suggested the Lung-MAP trial design to speed new treatments to market and "minimize the number of patients exposed to ineffective therapies," he said.

Everyone in the study will be screened for mutations in more than 200 cancer-related genes, rather than a single mutation as in conventional studies.

Then they will be assigned to one of five groups based on what these tumor biomarkers show. Each group will test a particular experimental medicine. Drugs can be added or subtracted from the study as it goes on, based on how each performs.

The initial round of testing involves Amgen, Genentech, Pfizer, AstraZeneca PLC, and AstraZeneca's global biologics partner, MedImmune. Up to 1,000 patients a year can be enrolled in the study.

It will cost about $150 million. The National Cancer Institute is paying $25 million, and the rest will come from foundations, charities and others in the public-private partnership.

About 500 hospitals that are part of a large cancer treatment consortium around the country will take part, and some private groups want to join as well, Herbst said.

"Nothing like this has ever been done before," where such comprehensive testing will be done to match patients to experimental drugs, he said.

Breyan Harris, a 33-year-old nurse from Sacramento, hopes to enroll. She's a lifelong non-smoker who was diagnosed with lung cancer on June 3.

"Since then I've pretty much been on the phone, seeing doctors, trying to figure out how do I get rid of this," she said. Harris expects to have one lung with a large tumor removed, "but if it comes back in my other lung I'm in real trouble," so finding a drug to attack any remaining, hidden cancer is crucial, she said.

Online:  

Copyright 2014 The Associated Press

Monday, May 19, 2014

Bonnie J. Addario Lung Cancer Foundation and Van Auken Private Foundation Announce the 2014 Young Innovators Team Award for Lung Cancer Research

Award will fund teams of young, brilliant thinkers for research focused on immediate impact on lung cancer patient lives

SAN CARLOS, CALIF. — The Bonnie J Addario Lung Cancer Foundation (ALCF), in collaboration with the Van Auken Private Foundation today announced the 2014 Young Innovators Team Award (YITA), a first-of-its-kind program that will fund and support teams of young investigators to conduct novel, innovative and transdisciplinary research with a potential of high clinical impact for lung cancer patients.

“In an effort to involve all stakeholders in our mission of making lung cancer a chronically managed disease by 2023, our goal with this program is to identify young, brilliant and collaborative out-of-the-box thinkers to deliver meaningful and measurable results in the field of lung cancer,” said Bonnie J. Addario, lung cancer survivor and founder of the ALCF.

The 2014 Young Innovator Team Award, with funding from both the Addario Lung Cancer Foundation and the Van Auken Private Foundation, will provide up to a total of $500,000 per team over a duration of 2-3 years, to teams of two or more young investigators – those within five years of their first faculty appointment (www.lungcancerfoundation.org/grants).

All submissions will be evaluated on the following four main criteria; that the proposed research be:
  • Out-of-the-box – High-risk, high-impact research that will typically not be selected for federal funding, is creative and has potential for near-term benefit to lung cancer patients.
  • Collaborative – Research that fosters collaboration among young researchers who haven’t worked together in the past, preferably across-institutions.
  • Translational – Research with outcomes that can be quickly moved from the lab to the clinic, or from the bench to bedside.
  • Multi-Disciplinary – Projects that involve multiple academic disciplines/specializations in their approach to solve a problem in the field of lung cancer.

“Not only is lung cancer the least funded cancer, proportionate to the amount of lives it claims,” said Tony Addario, CEO of the Addario Lung Cancer Medical Institute (ALCMI), the ALCF’s sister organization and an international research consortium, “but it attracts disproportionately fewer young, talented thinkers because there is such a lack of funding for research. We hope this award is the first step in changing that. We also want to encourage young innovators to work together and collaborate in a transdisciplinary fashion focused on solving lung cancer patients’ pressing unmet medical needs.”

The funding mechanism is designed in such a way that young investigators work together in cross-disciplinary teams and drive the projects, with guidance from mentors at their own institution, as well as the 2014 YITA Scientific Review Committee that will guide and steer their progress, and make final decisions on continued funding.

“The idea is to encourage new thinking and foster leadership skills among young innovators, instilling confidence in them to drive breakthrough, transdisciplinary science under a collaborative, cross-institutional paradigm,” said David Carbone, M.D., Ph.D. at The Ohio State University, and one of the ALCF Scientific Review Committee members.

The 2014 YITA Scientific Review Committee is comprised of four top global experts in the lung cancer field: David Carbone, M.D., Ph.D (The Ohio State University), David Gandara, M.D. (University of California, Davis), Roy Herbst, M.D., Ph.D (Yale School of Medicine), Giorgio Scagliotti, M.D., Ph.D. (University of Torino).

ALCF invites lung cancer patient-oriented research in the following topic areas preferably (however, all submissions will be evaluated):
  • Studies of mechanisms of lung cancer initiation, progression and metastases.
  • Development of new technologies for the detection, treatment and prevention of lung cancer.
  • Diagnostic and therapeutic interventions, preferably new diagnostics and treatments for metastatic lung cancer especially those targeting currently ‘undruggable’ mutations against which there is no available targeted therapy.
  • Early detection of lung cancer, especially via non-invasive tools.
  • Identification of mechanisms of resistance to current lung cancer modalities.
  • Translational research in metabolism and nutrition.

Key Dates:
RFA Announcement: May 19, 2014
  • Online Application Submission Portal Opens: June 3, 2014
  • Application Submission Deadline: August 1, 2014
  • Peer Review Deadline: August 30, 2014
  • Top 5 teams present to the Scientific Review Committee, in-person review: September 10, 2014
  • Award Announcements and Notification: September 30, 2014

For more information on the award, guidelines for submission, FAQs and the online submission portal please visit www.lungcancerfoundation.org/grants.

The Bonnie J. Addario Lung Cancer Foundation will accept online applications during 6/3 - 8/1, 2014.

Contact:
Guneet Walia, Ph.D.
Director, Research and Medical Affairs
Bonnie J. Addario Lung Cancer Foundation
1100 Industrial Road, #1
San Carlos, CA 94070
grants@lungcancerfoundation.org

Funding for this unique new award is provided by the Bonnie J. Addario Lung Cancer Foundation and the Van Auken Private Foundation.

About the Bonnie J. Addario Lung Cancer Foundation

The Bonnie J. Addario Lung Cancer Foundation is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, education, early detection, genetic testing, drug discovery and patient-focused outcomes. The Foundation’s commitment to lung cancer patients is to collaborate and partner with the leaders in oncology, technology, science, medicine and philanthropy to make Lung Cancer a chronically managed disease by 2023. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised more than $10 million for lung cancer research. To learn more, please visit www.lungcancerfoundation.org.

About the Van Auken Private Foundation

The Van Auken Private Foundation was established on April 17, 2008 as a 501(c)(3) non-profit organization. Its purpose is to make contributions, grants and provide assistance to other tax-exempt charitable organizations, in arts, science, medicine, education and worthy social causes.

Tuesday, April 15, 2014

Spotlite Radio Presents...

My interview with Sonia Williams of the BlogTalkRadio.com show, "Spotlite Radio"...

From April 15th, 2014.

For more information on lung cancer and how you can help, please visit The Joan Gaeta Lung Cancer Fund here.  If you are a Georgia resident, please consider a Lung Cancer Awareness License Plate and visit LungCancerLicensePlate.org.

Thank you.

Tuesday, April 8, 2014

The Bonnie J. Addario Lung Cancer Foundation Releases New Public Service Announcement Featuring Penny Marshall

April 07, 2014 12:37 PM Eastern Daylight Time

SAN CARLOS, Calif.--(BUSINESS WIRE)--The Bonnie J. Addario Lung Cancer Foundation (ALCF) today released the third in a series of Public Service Announcements featuring well-known celebrities to raise awareness for the nation's number one cancer killer. Film director and actress Penny Marshall, who is a lung cancer survivor, is featured in the new 30-second PSA.

"There are so many people who are not aware that lung cancer takes more lives every year than breast, prostate and colon cancers combined. The sad reality is that anyone can get lung cancer"

"There are so many people who are not aware that lung cancer takes more lives every year than breast, prostate and colon cancers combined. The sad reality is that anyone can get lung cancer," said Bonnie J. Addario, stage 3B lung cancer survivor and founder of the ALCF. "As a lung cancer survivor myself, I applaud Penny for helping us to raise awareness and educate patients so they can live longer."

Marshall is known for her acting as well as directing careers, having starred in the 1970s and 80s sitcom Laverne & Shirley and later going on to direct successful movies such as A League of Their Own and Big.

Previous lung cancer Public Service Announcements featuring Maroon 5 and former NFL Wide Receiver Hank Baskett can be viewed here on the Foundation's website.


About the Bonnie J. Addario Lung Cancer Foundation

The Bonnie J. Addario Lung Cancer Foundation is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, education, early detection, genetic testing, drug discovery and patient-focused outcomes. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised more than $10 million for lung cancer research. To learn more, please visit www.lungcancerfoundation.org.

Thursday, March 6, 2014

Non-Smoking Baltimore Orioles PR Director Monica Barlow Dies of Lung Cancer at 36

This story was originally published by CBS News on February 28th, 2014.
Picture
BALTIMORE (WJZ) - After a long battle with lung cancer, the Orioles director of public relations died Friday morning at age 36.

Monica Pence Barlow was diagnosed with stage IV lung cancer in September 2009.

"I was blown away by the diagnosis. I was just 32. I had never been a smoker, I had no family history of cancer, and I had always maintained a healthy lifestyle," she wrote in a an article posted on American Association for Cancer Research last year.

Barlow has been the O's PR director since April 2008.

Majority owner Peter Angelos released the following statement:
"It was with deep sadness that I learned of Monica's passing this morning. In her 14 years with the club, she was a beloved member of the Orioles family, starting as an intern and becoming director of public relations. Over the past four and a half years, the work Monica did to raise awareness and funds for cancer research was a testament to her dedication to helping others. The strength and resiliency she displayed by not letting her illness define her was a great inspiration to all who knew her. Her loss will be felt deeply by not only our front office staff, but also our manager, players and coaches, with whom she worked on a daily basis. On behalf of the club, I extend my condolences to her husband, Ben; her parents, Wayne and Ramona Pence; her brother, Jonah; her sister, Natalie; and her family and friends."
The team plays its first exhibition game in Port Charlotte, Fla. on Friday. Manager Buck Showalter broke the news to players before their drive.

He choked up when asked to say a few words about Barlow at a Friday morning presser, according to an article posted on MASN.

"I tried to text her every night before I went to bed," Showalter said. "Today was the first time I didn't get a returned one."

He released the following statement:
"We lost a feather from the Oriole today. Monica embodied everything we strive to be about. Her passion, loyalty and tenacity set a great example for everyone in the organization. She was so courageous in continuing to do her job the last few years despite her pain. This is an especially tough day for those of us that worked with her on a daily basis. It was a blessing to have her in my life. She made our jobs so much easier. We won't be able to replace Monica. We will only try to carry on. I am going to miss her as a colleague and a friend. She was a rock."
Barlow interned with the Orioles in 1999 and spent a year as PR assistant with the Richmond Braves.

Thursday, February 6, 2014

Advocacy Groups Move the Needle Forward. Tuesday, February 18th @ 8:30pm Eastern

Picture
On February 18, don't miss the leaders and armies of lung cancer advocacy groups as they align like the stars to discuss efforts to achieve the goal and raise funds to commit to this "cost of living with lung cancer."

Join members of the Bonnie J. Addario Lung Cancer Foundation, American Lung Association, Dusty Joy Foundation, Lung Cancer Foundation of America (LCFA), and Lungevity for an unprecedented collaboration in the fight to end lung cancer.

"Now that we've heard what the experts have to say, what can we do together to move the needle forward?" 
       - Danielle Beltramo - Hicks

Whether you join us in ALCF’s Living Room or attend remotely through Livestream on your computer, you will be informed about Living with Lung Cancer.

If you are having trouble getting the live stream working, click here for help and troubleshooting tips.
Picture
The Patient Handbook, “Navigating Lung Cancer, 360 Degrees of Hope,” is the first-ever comprehensive, up-to-date patient resource for Lung Cancer. 

For a hard copy of the handbook please emai lhandbook@lungcancerfoundation.org or click below to download a copy.
Picture